Comparison between DNA- and RNA-based nucleic acid amplification tests for detecting Mycoplasma pneumoniae in...

Area of Science:

• Pediatric infectious diseases
• Molecular diagnostics
• Microbiology

Background:

• Mycoplasma pneumoniae is a common cause of pneumonia in children and young adults.
• Molecular methods, including DNA- and RNA-based nucleic acid amplification tests (NAATs), are standard for diagnosis.
• RNA-based NAATs are thought to indicate pathogen viability, but direct clinical comparisons with DNA-based NAATs are limited.

Purpose of the Study:

• To compare the clinical performance of DNA- and RNA-based NAATs for Mycoplasma pneumoniae detection in pediatric samples.
• To investigate the underlying reasons for differential detection outcomes between DNA- and RNA-based NAATs.

Main Methods:

• Analysis of 3180 clinical Mycoplasma pneumoniae samples from pediatric patients (2018).
• Stratification by sample type, season, age, and sex.
• In vitro culture and cell infection models to elucidate differential detection mechanisms.

Main Results:

• DNA- and RNA-based NAAT performance varied, influenced by sample type and patient age, but not season or sex.
• In vitro studies showed Mycoplasma pneumoniae-RNA (MP-RNA) has faster synthesis and degradation rates.
• Mycoplasma pneumoniae-DNA (MP-DNA) demonstrated accumulation and longer persistence in pathogen growth dynamics.

Conclusions:

• Differential nucleic acid kinetics of Mycoplasma pneumoniae explain observed clinical detection variations.
• Findings support evidence-based selection of DNA- or RNA-based NAATs based on patient age and sample type.
• Improved reliable detection of Mycoplasma pneumoniae in children is anticipated.